Apothékary Launches ‘Every Phase’ to Address Growing Demand for Menopause Supplements
Amid an increasing global focus on natural solutions for women’s health, Japanese wellness brand Apothékary has officially entered the international women’s health arena with its latest innovation, Every Phase. This new offering is designed to address the widening ‘catch-up’ gap in non-hormone therapies available to women throughout their hormonal journey, particularly during menopause. Founder Shizu Okusa emphasized that Every Phase aims to broaden the spectrum of accessible non-hormonal solutions for women, supporting them at every stage of hormonal change. With menopause-related symptoms affecting millions worldwide, there is a pressing need for products that provide relief without resorting to hormonal intervention.
The launch comes at a time when awareness of natural menopause supplements is reaching new heights. The global market is witnessing a surge in demand for products that cater specifically to women experiencing perimenopausal and menopausal symptoms. In this context, Apothékary’s Every Phase seeks to empower women with safe, effective alternatives rooted in botanical ingredients and science-backed formulations. Okusa reiterated the brand’s commitment to closing gaps in care and enhancing women’s quality of life through innovative supplement solutions.
Scientific Advancements and Industry Expansion Fuel Menopause Supplement Market
Recent clinical research further underscores the potential of targeted supplementation in alleviating menopause-related symptoms. A randomized, double-blind, placebo-controlled trial investigating Xeya Modern Shatavari supplementation revealed promising results: perimenopausal women experienced reductions in hot flashes, fatigue, and sleep disturbances. These findings contribute to the growing body of evidence supporting non-hormonal interventions as viable options for symptom management during menopause.
In parallel with scientific advancements, industry players are strategically expanding their portfolios to tap into the burgeoning women’s supplement market, which is valued at $57.4 billion. Fertility-focused brands like Blueroot Health’s Fairhaven Health are broadening their reach beyond reproductive health to address wellness needs across all stages of a woman’s life. This shift reflects a deeper understanding of the interconnectedness between gut health, hormone balance, and overall well-being—areas such as the estrobolome and the gut-hormone axis are receiving increased attention as research links gut microbiome dynamics with hormone regulation and menopause symptomatology.
As consumer preferences evolve toward holistic and non-hormonal solutions, brands like Apothékary are poised to lead the charge in redefining menopause care. The launch of Every Phase marks a significant step forward in expanding options for women seeking natural relief from menopausal symptoms, underscoring a broader movement toward personalized, science-driven wellness strategies.
